GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Debt-to-Revenue

HLB Panagene Co (XKRX:046210) Debt-to-Revenue : 1.85 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

HLB Panagene Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩25,168 Mil. HLB Panagene Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩80 Mil. HLB Panagene Co's annualized Revenue for the quarter that ended in Mar. 2024 was ₩13,629 Mil. HLB Panagene Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 1.85.


HLB Panagene Co Debt-to-Revenue Historical Data

The historical data trend for HLB Panagene Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co Debt-to-Revenue Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.01 0.02 1.89

HLB Panagene Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 1.04 2.18 1.85

Competitive Comparison of HLB Panagene Co's Debt-to-Revenue

For the Biotechnology subindustry, HLB Panagene Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's Debt-to-Revenue falls into.



HLB Panagene Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

HLB Panagene Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(23115.64 + 89.367) / 12252.031
=1.89

HLB Panagene Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(25167.731 + 79.673) / 13629.28
=1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


HLB Panagene Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co (XKRX:046210) Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co (XKRX:046210) Headlines

No Headlines